55 related articles for article (PubMed ID: 18353050)
1. Multiple drug-resistant gene 1 in children with steroid-sensitive nephrotic syndrome.
Funaki S; Takahashi S; Wada N; Murakami H; Harada K
Pediatr Int; 2008 Apr; 50(2):159-61. PubMed ID: 18353050
[TBL] [Abstract][Full Text] [Related]
2. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.
Youssef DM; Attia TA; El-Shal AS; Abduelometty FA
Gene; 2013 Nov; 530(2):201-7. PubMed ID: 23994685
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukine-2 receptor and MDR1 gene expression levels as inflammatory biomarkers for prediction of steroid response in children with nephrotic syndrome.
Youssef DM; Elbehidy RM; Abdelhalim HS; Amr GE
Iran J Kidney Dis; 2011 Jul; 5(3):154-61. PubMed ID: 21525574
[TBL] [Abstract][Full Text] [Related]
4. [Interleukin-18 expression in peripheral blood mononuclear cells in children with steroid-resistant nephrotic syndrome].
Jiang HK; Luo G; Jiang H
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):337-40. PubMed ID: 19470251
[TBL] [Abstract][Full Text] [Related]
5. Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome.
Holt RC; Webb NJ; Ralph S; Davies J; Short CD; Brenchley PE
Kidney Int; 2005 Jan; 67(1):122-9. PubMed ID: 15610235
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome.
Aviles DH; Matti Vehaskari V; Manning J; Ochoa AC; Zea AH
Kidney Int; 2004 Jul; 66(1):60-7. PubMed ID: 15200413
[TBL] [Abstract][Full Text] [Related]
7. MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children.
Jafar T; Prasad N; Agarwal V; Mahdi A; Gupta A; Sharma RK; Negi MP; Agrawal S
Nephrol Dial Transplant; 2011 Dec; 26(12):3968-74. PubMed ID: 21460357
[TBL] [Abstract][Full Text] [Related]
8. Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome.
Webb NJ; Watson CJ; Roberts IS; Bottomley MJ; Jones CA; Lewis MA; Postlethwaite RJ; Brenchley PE
Kidney Int; 1999 Mar; 55(3):1063-71. PubMed ID: 10027945
[TBL] [Abstract][Full Text] [Related]
9. Differential alteration in peripheral T-regulatory and T-effector cells with change in P-glycoprotein expression in Childhood Nephrotic Syndrome: A longitudinal study.
Prasad N; Jaiswal AK; Agarwal V; Yadav B; Sharma RK; Rai M; Singh H; Chaturvedi S; Singh A
Cytokine; 2015 Apr; 72(2):190-6. PubMed ID: 25661194
[TBL] [Abstract][Full Text] [Related]
10. Human intestinal P-glycoprotein activity estimated by the model substrate digoxin.
Larsen UL; Hyldahl Olesen L; Guldborg Nyvold C; Eriksen J; Jakobsen P; Østergaard M; Autrup H; Andersen V
Scand J Clin Lab Invest; 2007; 67(2):123-34. PubMed ID: 17365992
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
Skrzypczyk P; Panczyk-Tomaszewska M; Roszkowska-Blaim M; Wawer Z; Bienias B; Zajgzkowska M; Kilis-Pstrusinska K; Jakubowska A; Szczepaniak M; Pawlak-Bratkowska M; Tkaczyk M
Clin Nephrol; 2014 Mar; 81(3):166-73. PubMed ID: 24361057
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary analysis of urinary proteomics in children with steroid-resistant and steroid-sensitive nephrotic syndrome].
Huang AW; He QN; Zhou P; Ding JJ; Yi ZW
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):341-5. PubMed ID: 19470252
[TBL] [Abstract][Full Text] [Related]
13. Expression of mdr1/P-glycoprotein and p110 in neuroblastoma.
Ramani P; Dewchand H
J Pathol; 1995 Jan; 175(1):13-22. PubMed ID: 7891222
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.
Nadali F; Pourfathollah AA; Alimoghaddam K; Nikougoftar M; Rostami S; Dizaji A; Azizi E; Zomorodipour A; Ghavamzadeh A
Hematology; 2007 Oct; 12(5):393-401. PubMed ID: 17852455
[TBL] [Abstract][Full Text] [Related]
16. Immunomagnetic purification of human breast carcinoma cells allows tumor-specific detection of multidrug resistance gene 1-mRNA by reverse transcriptase polymerase chain reaction in fine-needle aspirates.
Maas RA; Bruning PF; Breedijk AJ; Top B; Peterse HL
Lab Invest; 1995 Jun; 72(6):760-4. PubMed ID: 7540237
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of Pad1 homologue and multidrug resistance of idiopathic nephrotic syndrome.
Ma Z; Gao X; Zhao W; Li Y; Li C; Li C
Pediatr Int; 2009 Oct; 51(5):732-5. PubMed ID: 19419512
[TBL] [Abstract][Full Text] [Related]
18. 5-Lipoxygenase and leukotriene A4 hydrolase expression in primary nephrotic syndrome.
Bakr A; Hawas S; Slem S; Moniem AA; Ghatab T; Tawfik M
Pediatr Nephrol; 2004 Apr; 19(4):396-9. PubMed ID: 14986086
[TBL] [Abstract][Full Text] [Related]
19. [Heparanase expression of peripheral blood cells in steroid responsive nephrotic syndrome patients].
Yan Y; Wang Z; Tao YH
Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):199-201. PubMed ID: 15144715
[TBL] [Abstract][Full Text] [Related]
20. Association of eNOS gene intron 4 a/b VNTR polymorphisms in children with nephrotic syndrome.
Dursun H; Noyan A; Matyar S; Buyukcelik M; Soran M; Cengiz N; Bayazit AK; Seydaoglu G; Attila G; Anarat A
Gene; 2013 Jun; 522(2):192-5. PubMed ID: 23570878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
